BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1748033)

  • 1. Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
    Humphries TJ
    Dig Dis Sci; 1991 Dec; 36(12):1665-9. PubMed ID: 1748033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famotidine: a notable lack of drug interactions.
    Humphries TJ
    Scand J Gastroenterol Suppl; 1987; 134():55-60. PubMed ID: 2889260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of pantoprazole drug interactions in man.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):385-99. PubMed ID: 7981922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
    Slusher LB; Park SS; Gelboin HV; Vesell ES
    Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].
    Klotz U; Reimann I
    Klin Wochenschr; 1983 Jul; 61(13):625-32. PubMed ID: 6136626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.
    Gugler R; Jensen JC
    Gastroenterology; 1985 Dec; 89(6):1235-41. PubMed ID: 3932118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole drug interaction studies.
    Andersson T
    Clin Pharmacokinet; 1991 Sep; 21(3):195-212. PubMed ID: 1764870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole: effects on oxidative drug metabolism in the rat.
    Henry DA; Gerkens JF; Brent PJ; Dosen PJ
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):377-81. PubMed ID: 3742882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
    Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
    Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Omeprazole and liver functions].
    Sauvet P; Schouler L
    Rev Med Interne; 1992; 13(5):359-63. PubMed ID: 1344831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omeprazole on ethanol oxidation and aniline hydroxylation in rat hepatic microsomes.
    Seitz HK; Simanowski UA; Simon B; Kommerell B
    Z Gastroenterol; 1988 Mar; 26(3):188-90. PubMed ID: 3043944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.
    Ishizaki T; Chiba K; Manabe K; Koyama E; Hayashi M; Yasuda S; Horai Y; Tomono Y; Yamato C; Toyoki T
    Clin Pharmacol Ther; 1995 Aug; 58(2):155-64. PubMed ID: 7648765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: omeprazole and the cytochrome P450 system.
    Petersen KU
    Aliment Pharmacol Ther; 1995 Feb; 9(1):1-9. PubMed ID: 7766737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of potential proton-pump inhibitor drug interactions: a retrospective review of prescriptions in community pharmacies.
    Saltiel E; Fask A
    Clin Ther; 1999 Oct; 21(10):1812-9. PubMed ID: 10566575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivo.
    Chenery RJ; Ayrton A; Oldham HG; Norman SJ; Standring P
    Biochem Pharmacol; 1988 Apr; 37(7):1407-14. PubMed ID: 3258518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cimetidine with other drugs.
    Feely J
    South Med J; 1983 Jun; 76(6):753-8. PubMed ID: 6344228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.
    Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E
    Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.